Search results
AstraZeneca's rare disease arm in $1 billion deal for Pfizer gene therapies
Reuters via Yahoo Finance· 10 months ago(Reuters) -AstraZeneca said on Friday its Alexion unit had agreed to buy U.S. drugmaker Pfizer's...
AstraZeneca hails heart disease breakthrough after patient trials
Evening Standard via Yahoo News· 2 years agoBritish pharma giant AstraZeneca said its Farxiga drug significantly lowers death in patients who...
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
Investor's Business Daily· 1 year agoAstraZeneca on Monday said it has agreed to buy CinCor Pharma, maker of clinical-stage blood...
AstraZeneca: New COVID drug may guard against all variants of concern
CBS News via Yahoo News· 1 year agoA replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised...
AstraZeneca seeks to calm CEO speculation after shares drop
Reuters via Yahoo Finance· 9 months agoLONDON (Reuters) -AstraZeneca appeared to play down speculation about the future of its CEO after...
FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For...
Benzinga via Yahoo Finance· 2 years agoThe FDA's Pulmonary-Allergy Drugs Advisory Committee has voted 16 to 1 that the data support a...
AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal
Reuters via Yahoo Finance· 1 year ago(Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor...
AstraZeneca to buy U.S. biotech CinCor for as much as $1.8 billion
Investing.com via Yahoo Finance· 1 year agoBy Scott Kanowsky Investing.com -- AstraZeneca PLC (LON:AZN) has agreed to acquire U.S. biotech CinCor Pharma Inc (NASDAQ:CINC) in a deal worth as much as $1.8 billion, as the Anglo-Swedish ...